VWA
MRNA icon

Visionary Wealth Advisors’s Moderna MRNA Stock Holding History

Visionary Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,407
Closed -$286K – 547
2024
Q2 		$286K Hold
2,407
– – 0.02% 419
2024
Q1 		$256K Buy
+2,407
New +$243K 0.02% 424
2022
Q2 		– Sell
-1,328
Closed -$229K – 462
2022
Q1 		$229K Buy
1,328
+195
+17% +$32.8K 0.02% 380
2021
Q4 		$288K Buy
+1,133
New +$331K 0.02% 298

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Visionary Wealth Advisors's MRNA Position: Q3 2024 in Review

Visionary Wealth Advisors sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,407 shares — an estimated $286K sold.

Visionary Wealth Advisors first reported a position in MRNA in Q4 2021 and held it in 4 quarters. The position peaked at $288K in Q4 2021. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Visionary Wealth Advisors reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Visionary Wealth Advisors sold 2,407 Moderna shares in Q3 2024, an estimated $286K.
  • Visionary Wealth Advisors first reported a position in Moderna in Q4 2021 and held it in 4 quarters.
  • Visionary Wealth Advisors's Moderna position peaked at $288K in Q4 2021.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Visionary Wealth Advisors's 13F filing for Q3 2024, filed 12 Nov 2024.